|
Real-time Estimate
Cboe BZX
12:39:24 12/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 1.470 USD | -3.29% |
|
-9.21% | -71.87% |
| Market Cap | 2.67Cr 2.3Cr 2.18Cr 1.98Cr 3.71Cr 255.42Cr 3.73Cr 26Cr 9.96Cr 129.94Cr 10Cr 9.82Cr 410.61Cr | P/E 2026 * |
-0.5x | P/E 2027 * | -0.24x |
|---|---|---|---|---|---|
| Enterprise Value | 2.12Cr 1.82Cr 1.73Cr 1.57Cr 2.94Cr 202.36Cr 2.95Cr 21Cr 7.89Cr 102.95Cr 7.95Cr 7.78Cr 325.31Cr | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 3.58x |
| Free-Float |
93.16% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVM | Delayed | |
CBOE
| CVM | Real-time | |
|
Deutsche Boerse AG
| LSR | Delayed |
| 19/23/19 | Wall Street sluit hoger | |
| 19/23/19 | Wall Street op winst | |
| 18/23/18 | Wall Street richting licht rode opening | |
| 18/23/18 | Futures voorspellen terughoudende opening Wall Street | |
| 28/21/28 | Cel-Sci presenteert positieve onderzoeksdata immunotherapie |
| 1 day | -3.29% | ||
| 1 week | -9.21% | ||
| Current month | -8.65% | ||
| 1 month | -2.64% | ||
| 3 months | +33.32% | ||
| 6 months | -60.00% | ||
| Current year | -71.87% |
| 1 week | 1.47 |  | 1.76 |
| 1 month | 1.34 | | 1.76 |
| Current year | 0.89 | | 6.75 |
| 1 year | 0.89 | | 10.83 |
| 3 years | 0.89 | | 96.91 |
| 5 years | 0.89 | | 387.04 |
| 10 years | 0.89 | | 1,227.42 |
| Manager | Title | Age | Since |
|---|---|---|---|
Geert Kersten
CEO | Chief Executive Officer | 67 | 01/01/1995 |
Patricia Prichep
DFI | Director of Finance/CFO | 75 | 13/11/2024 |
| Chief Tech/Sci/R&D Officer | - | 01/05/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Geert Kersten
BRD | Director/Board Member | 67 | 01/01/1995 |
| Director/Board Member | 73 | 22/06/2015 | |
Bob Watson
CHM | Chairman | 69 | 08/07/2024 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 25/08/26 | Buy | Chief Executive Officer | 1,00,000 | 0.5722% | ||
| 14/08/26 | Free | Chief Financial Officer | 2,25,000 | 1.2874% | ||
| 14/08/26 | Free | Director | 1,10,000 | 0.6294% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -3.29% | -9.21% | -84.95% | -96.02% | 2.67Cr | |
| -2.11% | -3.44% | +41.04% | +98.48% | 6.82TCr | |
| -0.23% | -4.45% | +30.39% | +73.64% | 6.22TCr | |
| +1.94% | +2.91% | -10.85% | +390.45% | 2.78TCr | |
| -1.05% | -7.30% | +25.00% | +12.31% | 2.49TCr | |
| +0.50% | -6.57% | -7.06% | -17.81% | 2.42TCr | |
| +0.43% | -3.37% | +14.85% | -19.29% | 1.94TCr | |
| -3.03% | -5.19% | +192.88% | +340.13% | 1.73TCr | |
| -1.94% | -6.36% | -7.05% | +516.16% | 1.45TCr | |
| -2.05% | -4.25% | +44.61% | +156.93% | 1.42TCr | |
| Average | -1.08% | -4.12% | +23.89% | +145.50% | 2.73TCr | |
| Weighted average by Cap. | -0.80% | -3.80% | +32.97% | +136.52% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 59.72L 51.45L 48.72L 44.16L 82.85L 57Cr 83.27L 5.79Cr 2.23Cr 29Cr 2.24Cr 2.19Cr 92Cr |
| Net income | -2.51Cr -2.16Cr -2.05Cr -1.85Cr -3.48Cr -239.64Cr -3.5Cr -24Cr -9.35Cr -121.92Cr -9.42Cr -9.21Cr -385.25Cr | -2.95Cr -2.54Cr -2.41Cr -2.18Cr -4.09Cr -281.96Cr -4.12Cr -29Cr -11Cr -143.45Cr -11Cr -11Cr -453.29Cr |
| Net Debt | -55.54L -47.85L -45.31L -41.07L -77.05L -53Cr -77.44L -5.38Cr -2.07Cr -27Cr -2.09Cr -2.04Cr -85Cr | -53.39L -46L -43.56L -39.48L -74.07L -51Cr -74.44L -5.17Cr -1.99Cr -26Cr -2.01Cr -1.96Cr -82Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | $1.470 | -3.29% | 76,421 |
| 10/26/10 | $1.520 | -1.30% | 75,964 |
| 09/26/09 | $1.540 | -6.67% | 85,822 |
| 08/26/08 | $1.650 | +1.23% | 2,83,876 |
| 04/26/04 | $1.630 | +1.24% | 75,071 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Annual profits - Rate of surprise
- Stock Market
- Stocks
- CVM Stock
Select your edition
All financial news and data tailored to specific country editions
